Shirwan H - Search Results

1

Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting.

Miller MS, Allen PJ, Brown PH, Chan AT, Clapper ML, Dashwood RH, Demehri S, Disis ML, DuBois RN, Glynn RJ, Kensler TW, Khan SA, Johnson BD, Liby KT, Lipkin SM, Mallery SR, Meuillet EJ, Roden RBS, Schoen RE, Sharp ZD, Shirwan H, Siegfried JM, Rao CV, You M, Vilar E, Szabo E, Mohammed A. Miller MS, et al. Among authors: shirwan h. J Cancer Prev. 2021 Mar 30;26(1):71-82. doi: 10.15430/JCP.2021.26.1.71. J Cancer Prev. 2021. PMID: 33842408 Free PMC article.

2

Delayed graft rejection in autoimmune islet transplantation via biomaterial immunotherapy.

Coronel MM, Linderman SW, Martin KE, Hunckler MD, Medina JD, Barber G, Riley K, Yolcu ES, Shirwan H, García AJ. Coronel MM, et al. Among authors: shirwan h. Am J Transplant. 2023 Nov;23(11):1709-1722. doi: 10.1016/j.ajt.2023.07.023. Epub 2023 Aug 3. Am J Transplant. 2023. PMID: 37543091

3

A Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4⁺ T and Natural Killer Cells.

Barsoumian HB, Batra L, Shrestha P, Bowen WS, Zhao H, Egilmez NK, Gomez-Gutierrez JG, Yolcu ES, Shirwan H. Barsoumian HB, et al. Among authors: shirwan h. Cancer Res. 2019 Feb 15;79(4):783-794. doi: 10.1158/0008-5472.CAN-18-2401. Cancer Res. 2019. PMID: 30770367 Free PMC article.

4

Current challenges for cancer vaccine adjuvant development.

Bowen WS, Svrivastava AK, Batra L, Barsoumian H, Shirwan H. Bowen WS, et al. Among authors: shirwan h. Expert Rev Vaccines. 2018 Mar;17(3):207-215. doi: 10.1080/14760584.2018.1434000. Epub 2018 Feb 8. Expert Rev Vaccines. 2018. PMID: 29372660 Free PMC article. Review.

5

Intrathymic immune regulation with donor class I allopeptides leads to the development of immunoregulatory cells that maintain tolerance to cardiac allografts.

Shirwan H, Mhoyan A, Yolcu E, Ibrahim S. Shirwan H, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):80. doi: 10.1016/s0041-1345(00)01912-6. Transplant Proc. 2001. PMID: 11266712 No abstract available.

6

Autoimmune responses regulate alloimmunity for prolonged cardiac allograft survival.

Yolcu E, Fang J, Shirwan H. Yolcu E, et al. Among authors: shirwan h. Transplant Proc. 2001 Feb-Mar;33(1-2):93. doi: 10.1016/s0041-1345(00)01920-5. Transplant Proc. 2001. PMID: 11266721 No abstract available.

7

Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection.

Yolcu ES, Askenasy N, Singh NP, Cherradi SE, Shirwan H. Yolcu ES, et al. Among authors: shirwan h. Immunity. 2002 Dec;17(6):795-808. doi: 10.1016/s1074-7613(02)00482-x. Immunity. 2002. PMID: 12479825 Free article.

8

Display of Fas ligand protein on cardiac vasculature as a novel means of regulating allograft rejection.

Askenasy N, Yolcu ES, Wang Z, Shirwan H. Askenasy N, et al. Among authors: shirwan h. Circulation. 2003 Mar 25;107(11):1525-31. doi: 10.1161/01.cir.0000064893.96179.7e. Circulation. 2003. PMID: 12654611

9

Predominant expression of the Th2 response in chronic cardiac allograft rejection.

Mhoyan A, Wu GD, Kakoulidis TP, Que X, Yolcu ES, Cramer DV, Shirwan H. Mhoyan A, et al. Among authors: shirwan h. Transpl Int. 2003 Aug;16(8):464-73. doi: 10.1007/s00147-003-0590-6. Epub 2003 Apr 24. Transpl Int. 2003. PMID: 12712237

10

Prevention of chronic rejection with immunoregulatory cells induced by intrathymic immune modulation with class I allopeptides.

Shirwan H, Mhoyan A, Kakoulidis TP, Yolcu ES, Ibrahim S. Shirwan H, et al. Am J Transplant. 2003 May;3(5):581-9. doi: 10.1034/j.1600-6143.2003.00052.x. Am J Transplant. 2003. PMID: 12752314 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page